trending Market Intelligence /marketintelligence/en/news-insights/trending/GWt8au9_pBTjAWexJwn4sg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

BioTime plans common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


BioTime plans common stock offering

BioTime Inc. plans to sell common shares in an underwritten public offering.

The company plans to grant the underwriters an overallotment option to buy up to an additional 15% of the shares offered.

BioTime plans to use the net proceeds for general corporate purposes, including, without limitation, to fund clinical trials of products it is developing, to finance its research and development programs, and for working capital.

Raymond James & Associates Inc. will act as the sole book-running manager for the offering.